Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112825 · ClinicalTrials.gov registry record · NA
Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease
A NA study of Focus Chronic Kidney Disease With Hypertension, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02112825: Completed NA study of Focus Chronic Kidney Disease With Hypertension, sponsored by University of Minnesota.
NCT02112825 is a NA study of Focus Chronic Kidney Disease With Hypertension that has completed, run by University of Minnesota. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02112825, a NA study of Focus Chronic Kidney Disease With Hypertension, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.
Primary Outcome
resting and 24-hour ambulatory blood pressure
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02112825 record still lists
NCT02112825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Focus Chronic Kidney Disease With Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT02112825 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02112825 about?
NCT02112825 is a clinical study titled "Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease". The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.
What is the current status of trial NCT02112825?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2013-07. Estimated completion is 2015-06.
What conditions does trial NCT02112825 study?
This clinical trial studies the following conditions: Focus Chronic Kidney Disease With Hypertension.
What interventions are being tested in trial NCT02112825?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112825?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02112825 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02112825's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia